Dogwood Therapeutics, Inc. (DWTX) — Tangible Net Worth Ratio
Dogwood Therapeutics, Inc. (DWTX) has a Tangible Net Worth Ratio of 12.2% as of September 2025. This metric is calculated by deducting intangible assets ($67.92 Million) from net assets ($77.39 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Dogwood Therapeutics, Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Dogwood Therapeutics, Inc. Tangible Net Worth Ratio (2020–2024)
This chart shows how Dogwood Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 12.2%, reflecting net assets of $77.39 Million with intangible assets of $67.92 Million USD.
Annual Tangible Net Worth Ratio for Dogwood Therapeutics, Inc. (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Dogwood Therapeutics, Inc. from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see DWTX market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -2.2% | $64.28 Million | $65.71 Million | $94.31 Million | ▼ -102.2 pp |
| 2023 | 100.0% | $3.81 Million | $0.00 | $4.17 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $7.33 Million | $0.00 | $8.37 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $14.50 Million | $0.00 | $15.78 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $29.94 Million | $0.00 | $31.47 Million | — |